Friedman JM. Epidemiology of neurofibromatosis type 1. Am J Med Genet. 1999;89:1–6.

CAS  PubMed  Article  Google Scholar 

Cimino PJ, Gutmann DH Chapter 51 - Neurofibromatosis type 1. In: Geschwind DH, Paulson HL, Klein C, editors. Handbook of Clinical Neurology. 148: Elsevier; 2018. p. 799-811.

Leier A, Bedwell DM, Chen AT, Dickson G, Keeling KM, Kesterson RA, et al. Mutation-Directed Therapeutics for Neurofibromatosis Type I. Mol Ther - Nucleic Acids. 2020;20:739–53.

CAS  PubMed  PubMed Central  Article  Google Scholar 

DeClue JE, Cohen BD, Lowy DR. Identification and characterization of the neurofibromatosis type 1 protein product. Proc Natl Acad Sci. 1991;88:9914–8.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Gutmann DH, Wood DL, Collins FS. Identification of the neurofibromatosis type 1 gene product. Proc Natl Acad Sci. 1991;88:9658–62.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Bernards A, Snijders AJ, Hannigan GE, Murthy AE, Gusella JF. Mouse neurofibromatosis type 1 cDNA sequence reveals high degree of conservation of both coding and non-coding mRNA segments. Hum Mol Genet. 1993;2:645–50.

CAS  PubMed  Article  Google Scholar 

Gutmann DH, Collins FS. The neurofibromatosis type 1 gene and its protein product, neurofibromin. Neuron 1993;10:335–43.

CAS  PubMed  Article  Google Scholar 

Xu GF, O’Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990;62:599–608.

CAS  PubMed  Article  Google Scholar 

Martin GA, Viskochil D, Bollag G, McCabe PC, Crosier WJ, Haubruck H, et al. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 1990;63:843–9.

CAS  PubMed  Article  Google Scholar 

Ballester R, Marchuk D, Boguski M, Saulino A, Letcher R, Wigler M, et al. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 1990;63:851–9.

CAS  PubMed  Article  Google Scholar 

Kim HA, Ratner N, Roberts TM, Stiles CD. Schwann cell proliferative responses to cAMP and Nf1 are mediated by cyclin D1. J Neurosci. 2001;21:1110–6.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Dasgupta B, Dugan LL, Gutmann DH. The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes. J Neurosci. 2003;23:8949–54.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Hegedus B, Dasgupta B, Shin JE, Emnett RJ, Hart-Mahon EK, Elghazi L, et al. Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and Ras-dependent mechanisms. Cell Stem Cell. 2007;1:443–57.

CAS  PubMed  Article  Google Scholar 

Brown JA, Diggs-Andrews KA, Gianino SM, Gutmann DH. Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP/PKA/ROCK-dependent manner. Mol Cell Neurosci. 2012;49:13–22.

CAS  PubMed  Article  Google Scholar 

Philpott C, Tovell H, Frayling IM, Cooper DN, Upadhyaya M. The NF1 somatic mutational landscape in sporadic human cancers. Hum Genomics. 2017;11:13.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ. Neurofibromatosis type 1. Nat Rev Dis Prim. 2017;3:17004.

PubMed  Article  Google Scholar 

Stenson PD, Mort M, Ball EV, Chapman M, Evans K, Azevedo L, et al. The Human Gene Mutation Database (HGMD((R))): optimizing its use in a clinical diagnostic or research setting. Hum Genet. 2020;139:1197–207.

PubMed  PubMed Central  Article  Google Scholar 

He F, Jacobson A. Nonsense-Mediated mRNA Decay: Degradation of Defective Transcripts Is Only Part of the Story. Annu Rev Genet. 2015;49:339–66.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Osborn MJ, Upadhyaya M. Evaluation of the protein truncation test and mutation detection in the NF1 gene: mutational analysis of 15 known and 40 unknown mutations. Hum Genet. 1999;105:327–32.

CAS  PubMed  Article  Google Scholar 

Miller JN, Pearce DA. Nonsense-mediated decay in genetic disease: Friend or foe? Mutat Res. 2014;762:52–64.

CAS  Article  Google Scholar 

Bashyam MD. Nonsense-mediated decay: linking a basic cellular process to human disease. Expert Rev Mol Diagn. 2009;9:299–303.

PubMed  Article  Google Scholar 

Anastasaki C, Morris SM, Gao F, Gutmann DH. Children with 5’-end NF1 gene mutations are more likely to have glioma. Neurol Genet. 2017;3:e192.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Brinckmann A, Mischung C, Bassmann I, Kuhnisch J, Schuelke M, Tinschert S, et al. Detection of novel NF1 mutations and rapid mutation prescreening with Pyrosequencing. Electrophoresis 2007;28:4295–301.

CAS  PubMed  Article  Google Scholar 

Keeling KM, Xue X, Gunn G, Bedwell DM. Therapeutics Based on Stop Codon Readthrough. Annu Rev Genomics Hum Genet. 2014;15:8.1–8.

Article  CAS  Google Scholar 

Peltz SW, Morsy M, Welch EM, Jacobson A. Ataluren as an agent for therapeutic nonsense suppression. Annu Rev Med. 2013;64:407–25.

CAS  PubMed  Article  Google Scholar 

Welch EM, Barton ER, Zhuo J, Tomizawa Y, Friesen WJ, Trifillis P, et al. PTC124 targets genetic disorders caused by nonsense mutations. Nature. 2007;447:87–91.

CAS  PubMed  Article  Google Scholar 

Li M, Andersson-Lendahl M, Sejersen T, Arner A. Muscle dysfunction and structural defects of dystrophin-null sapje mutant zebrafish larvae are rescued by ataluren treatment. FASEB J. 2014;28:1593–9.

CAS  PubMed  Article  Google Scholar 

Gregory-Evans CY, Wang X, Wasan KM, Zhao J, Metcalfe AL, Gregory-Evans K. Postnatal manipulation of Pax6 dosage reverses congenital tissue malformation defects. J Clin Invest. 2014;124:111–6.

CAS  PubMed  Article  Google Scholar 

Bushby K, Finkel R, Wong B, Barohn R, Campbell C, Comi GP, et al. Ataluren treatment of patients with nonsense mutation dystrophinopathy. Muscle Nerve. 2014;50:477–87.

CAS  PubMed  Article  Google Scholar 

Ryan NJ. Ataluren: first global approval. Drugs 2014;74:1709–14.

CAS  PubMed  Article  Google Scholar 

Li K, Turner AN, Chen M, Brosius SN, Schoeb TR, Messiaen LM, et al. Mice with missense and nonsense NF1 mutations display divergent phenotypes compared with human neurofibromatosis type I. Dis Model Mech. 2016;9:759–67.

CAS  PubMed  PubMed Central  Google Scholar 

Kocova M, Kochova E, Sukarova-Angelovska E. Optic glioma and precocious puberty in a girl with neurofibromatosis type 1 carrying an R681X mutation of NF1: case report and review of the literature. BMC Endocr Disord. 2015;15:82.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Toonen JA, Anastasaki C, Smithson LJ, Gianino SM, Li K, Kesterson RA, et al. NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1. Hum Mol Genet. 2016;25:1703–13.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Gaspard N, Bouschet T, Herpoel A, Naeije G, van den Ameele J, Vanderhaeghen P. Generation of cortical neurons from mouse embryonic stem cells. Nat Protoc. 2009;4:1454–63.

CAS  PubMed  Article  Google Scholar 

Iyer S, Suresh S, Guo D, Daman K, Chen JCJ, Liu P, et al. Precise therapeutic gene correction by a simple nuclease-induced double-stranded break. Nature. 2019;568:561–5.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Bae S, Park J, Kim J-S. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics 2014;30:1473–5.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Costa ADA, Gutmann DH Brain tumors in neurofibromatosis type 1. Neuro-Oncology Advances. 2019;2(Supplement_1):i85-i97.

Guilding C, McNair K, Stone TW, Morris BJ. Restored plasticity in a mouse model of neurofibromatosis type 1 via inhibition of hyperactive ERK and CREB. Eur J Neurosci. 2007;25:99–105.

PubMed  Article  Google Scholar 

Cui Y, Costa RM, Murphy GG, Elgersma Y, Zhu Y, Gutmann DH, et al. Neurofibromin Regulation of ERK Signaling Modulates GABA Release and Learning. Cell 2008;135:549–60.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Pan Y, Hysinger JD, Barron T, Schindler NF, Cobb O, Guo